Insights into the Pathogenesis of HS and Therapeutical Approaches

Hidradenitis suppurativa (HS) is a debilitating, chronic, (auto)inflammatory disease primarily affecting apocrine gland-rich areas of the body. Although pathogenic mechanisms responsible for HS have not yet been fully elucidated, it is a multifactorial process whose main target is the terminal follicle. The role of the inflammatory process (and consequently of cytokine milieu) and of several other factors (genetics, lifestyle, hormonal status, microbiome, innate and adaptive immune systems) involved in HS pathogenesis has been investigated (and often defined) over the years with a view to transferring research results from bench to bedside and describing a unique and universally accepted pathogenetic model. This review will update readers on recent advances in our understanding of HS pathogenesis and novel (potential) medical therapies for patients with moderate-to-severe HS.

Automated summary

Hidradenitis suppurativa (HS) is a chronic, inflammatory disease primarily affecting apocrine gland-rich areas of the body. The pathogenic mechanisms of HS involve multiple factors, with the terminal follicle being the main target. Research has focused on investigating the role of inflammation, genetics, lifestyle, hormonal status, microbiome, and immune systems in HS pathogenesis to develop potential medical therapies for patients.